Mirum Pharmaceuticals Inc
F:08D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mirum Pharmaceuticals Inc
F:08D
|
US |
|
E
|
Euronext Athens Holding SA
XMUN:HEE
|
GR |
|
R
|
Realord Group Holdings Ltd
F:CUV
|
HK |
|
Y
|
Yext Inc
F:0YE
|
US |
|
Austriacard Holdings AG
F:ACQ0
|
AT |
|
G
|
Gladstone Capital Corp
NASDAQ:GLAD
|
US |
|
R
|
RomReal Ltd
F:3RR
|
BM |
|
R
|
RMA Global Ltd
ASX:RMY
|
AU |
|
First Capital Inc
NASDAQ:FCAP
|
US |
|
H
|
Hawesko Holding SE
DUS:HAW
|
DE |
|
D
|
Domino's Pizza Group PLC
SWB:DKOB
|
UK |
|
M
|
Mayora Indah Tbk PT
XMUN:D7V
|
ID |
|
Caisse Regionale De Credit Agricole Mutuel Toulouse 31
PAR:CAT31
|
FR |
|
Sarana Meditama Metropolitan Tbk PT
IDX:SAME
|
ID |
|
G
|
Grande Portage Resources Ltd
F:GPB
|
CA |
|
E
|
El Pollo Loco Holdings Inc
F:EP6
|
US |
|
M
|
Mathios Refractory SA
ATHEX:MATHIO
|
GR |
|
S
|
SyntekaBio Inc
KOSDAQ:226330
|
KR |
|
A
|
ABICO NetCom Co Ltd
TPEX:8071
|
TW |
|
Royalindo Investa Wijaya Tbk PT
IDX:INDO
|
ID |
|
A
|
ABS-CBN Corporation
XPHS:ABS
|
PH |
Bankruptcy Probability
Mirum Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mirum Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
|
5.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
471.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
217.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
74.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mirum Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mirum Pharmaceuticals Inc has total debt of 750.1m USD. This includes both short-term (0 USD) and long-term (750.1m USD) debt.
You can find a full breakdown on its Balance Sheet.